Protalix BioTherapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLX and other ETFs, options, and stocks.

About PLX

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11.

CEO

Dror Bashan

CEODror Bashan

Employees

208

Employees208

Headquarters

Hackensack, New Jersey

HeadquartersHackensack, New Jersey

Founded

1993

Founded1993

Employees

208

Employees208

PLX Key Statistics

Market cap

89.12M

Market cap89.12M

Price-Earnings ratio

13.84

Price-Earnings ratio13.84

Dividend yield

—

Dividend yield—

Average volume

340.73K

Average volume340.73K

High today

$1.23

High today$1.23

Low today

$1.17

Low today$1.17

Open price

$1.19

Open price$1.19

Volume

227.21K

Volume227.21K

52 Week high

$3.55

52 Week high$3.55

52 Week low

$1.09

52 Week low$1.09

Protalix BioTherapeutics

Why Robinhood?

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. Show more

PLX Key Statistics

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11.